BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 2411399)

  • 1. Enhancement by uridine of the anabolism of 5-fluorouracil in mouse T-lymphoma (S-49) cells.
    Parker WB; Klubes P
    Cancer Res; 1985 Sep; 45(9):4249-56. PubMed ID: 2411399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dissociation of 5-fluorouracil-induced DNA fragmentation from either its incorporation into DNA or its cytotoxicity in murine T-lymphoma (S-49) cells.
    Parker WB; Kennedy KA; Klubes P
    Cancer Res; 1987 Feb; 47(4):979-82. PubMed ID: 3802103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determinants of cytotoxicity with prolonged exposure to fluorouracil in human colon cancer cells.
    Ren Q; Van Groeningen CJ; Hardcastle A; Aherne GW; Geoffroy F; Allegra CJ; Johnston PG; Grem JL
    Oncol Res; 1997; 9(2):77-88. PubMed ID: 9167189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced cytotoxicity with interleukin-1 alpha and 5-fluorouracil in HCT116 colon cancer cells.
    Geoffroy FJ; Allegra CJ; Sinha B; Grem JL
    Oncol Res; 1994; 6(12):581-91. PubMed ID: 7787251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alteration of fluorouracil metabolism in human colon cancer cells by dipyridamole with a selective increase in fluorodeoxyuridine monophosphate levels.
    Grem JL; Fischer PH
    Cancer Res; 1986 Dec; 46(12 Pt 1):6191-9. PubMed ID: 2946402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sensitivity of human, murine, and rat cells to 5-fluorouracil and 5'-deoxy-5-fluorouridine in relation to drug-metabolizing enzymes.
    Peters GJ; Laurensse E; Leyva A; Lankelma J; Pinedo HM
    Cancer Res; 1986 Jan; 46(1):20-8. PubMed ID: 2415245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 5-Fluorouracil enhances azidothymidine cytotoxicity: in vitro, in vivo, and biochemical studies.
    Brunetti I; Falcone A; Calabresi P; Goulette FA; Darnowski JW
    Cancer Res; 1990 Jul; 50(13):4026-31. PubMed ID: 2354452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 5-Fluorouracil incorporation into DNA of CF-1 mouse bone marrow cells as a possible mechanism of toxicity.
    Schuetz JD; Wallace HJ; Diasio RB
    Cancer Res; 1984 Apr; 44(4):1358-63. PubMed ID: 6704957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incorporation of 5-fluorouracil into murine bone marrow DNA in vivo.
    Sawyer RC; Stolfi RL; Martin DS; Spiegelman S
    Cancer Res; 1984 May; 44(5):1847-51. PubMed ID: 6713387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of 5-fluorouracil catabolism in isolated rat hepatocytes with enhancement of 5-fluorouracil glucuronide formation.
    Sommadossi JP; Gewirtz DA; Cross DS; Goldman ID; Cano JP; Diasio RB
    Cancer Res; 1985 Jan; 45(1):116-21. PubMed ID: 3965128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of L-histidinol on the metabolism of 5-fluorouracil in the BALB/c x DBA/8 F1 murine tumor system.
    Sawyer RC; Stolfi RL; Martin DS
    Cancer Res; 1988 Dec; 48(23):6664-8. PubMed ID: 2460227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of 5-fluorouracil metabolism and cytotoxicity by antimetabolite pretreatment in human colorectal adenocarcinoma HCT-8.
    Benz C; Cadman E
    Cancer Res; 1981 Mar; 41(3):994-9. PubMed ID: 7459888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Augmentation of 5-fluorouracil cytotoxicity in human colon cancer cells by dipyridamole.
    Grem JL; Fischer PH
    Cancer Res; 1985 Jul; 45(7):2967-72. PubMed ID: 4005834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of cell lethality with incorporation of 5-fluorouracil and 5-fluorouridine into nuclear RNA in human colon carcinoma cells in culture.
    Glazer RI; Lloyd LS
    Mol Pharmacol; 1982 Mar; 21(2):468-73. PubMed ID: 7099147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of 5-fluorouracil metabolism in two human gastrointestinal tumor cell lines.
    Washtien WL
    Cancer Res; 1984 Mar; 44(3):909-14. PubMed ID: 6318987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between antitumor effect and metabolites of 5-fluorouracil in combination treatment with 5-fluorouracil and guanosine in ascites sarcoma 180 tumor system.
    Iigo M; Kuretani K; Hoshi A
    Cancer Res; 1983 Dec; 43(12 Pt 1):5687-94. PubMed ID: 6640523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel mechanism(s) of resistance to 5-fluorouracil in human colon cancer (HCT-8) sublines following exposure to two different clinically relevant dose schedules.
    Aschele C; Sobrero A; Faderan MA; Bertino JR
    Cancer Res; 1992 Apr; 52(7):1855-64. PubMed ID: 1532346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methotrexate inhibits the first committed step of purine biosynthesis in mitogen-stimulated human T-lymphocytes: a metabolic basis for efficacy in rheumatoid arthritis?
    Fairbanks LD; Rückemann K; Qiu Y; Hawrylowicz CM; Richards DF; Swaminathan R; Kirschbaum B; Simmonds HA
    Biochem J; 1999 Aug; 342 ( Pt 1)(Pt 1):143-52. PubMed ID: 10432311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of RNA- and DNA-directed actions of 5-fluoropyrimidines in mouse T-lymphoma (S-49) cells.
    Maybaum J; Ullman B; Mandel HG; Day JL; Sadee W
    Cancer Res; 1980 Nov; 40(11):4209-15. PubMed ID: 6451283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of 6-azauridine triphosphate in L1210 cells and its possible relevance to cytotoxicity.
    Wotring LL; Townsend LB
    Cancer Res; 1989 Jan; 49(2):289-94. PubMed ID: 2463073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.